Target intelligence / Profile preview

RAS family mRNA 3' untranslated regions (RAS 3'UTRs)

Target
RAS 3'UTRs
Molecular classification
RNA, mRNA regulatory element, Untranslated region
01

Overview

The RAS family mRNA 3' untranslated regions (3'UTRs) are non-coding segments of messenger RNA located downstream of the stop codon in KRAS, HRAS, and NRAS transcripts. These regions serve as critical regulatory hubs, containing binding sites for microRNAs (such as the let-7 family) and various RNA-binding proteins that dictate the stability, localization, and translation efficiency of RAS mRNAs (Johnson et al., 2005, Cell). In many cancers, alterations in these 3'UTRs—such as shortening through alternative polyadenylation or mutations in miRNA binding sites—lead to the evasion of post-transcriptional repression, resulting in the pathological overexpression of RAS proteins (Mayr & Bartel, 2009, Science). Consequently, these regions are being explored as therapeutic targets for RNA-based modalities, including antisense oligonucleotides and miRNA mimics, which aim to restore normal regulatory control or induce the degradation of oncogenic RAS transcripts. Targeting the 3'UTR offers a strategy to modulate RAS levels indirectly, potentially overcoming some of the challenges associated with directly inhibiting the "undruggable" RAS protein surfaces.

Other names
RAS 3'-untranslated regionsKRAS 3'UTRNRAS 3'UTRHRAS 3'UTRRAS mRNA regulatory regions
02

Mechanism of action

Modulation of mRNA stability and translation through RNA interference, antisense-mediated degradation, or competitive inhibition of regulatory protein/miRNA binding (Ross et al., 2017, Cancer Cell; Esquela-Kerscher & Slack, 2006, Nat Rev Cancer).

03

Biological functions

Regulation of mRNA stabilityTranslation regulationMicroRNA bindingPost-transcriptional regulation
04

Disease associations

CancerPancreatic cancerColorectal cancerNon-small cell lung cancer
05

Safety considerations

Off-target RNA bindingInnate immune activation by synthetic nucleic acidsSystemic delivery challengesSaturation of cellular RNAi machinery
06

Interacting drugs

AZD4785

3 more in the full profile.

07

Biomarkers

LCS6 SNP (rs712)RAS mRNA expression levelslet-7 family miRNA levels3'UTR length isoforms

Beyond the preview

Go deeper on RAS family mRNA 3' untranslated regions (RAS 3'UTRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAS family mRNA 3' untranslated regions (RAS 3'UTRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call